Tower Research Capital (TRC)’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
|
|||||
|
2025
Q1 | $1.02M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $283K | Buy |
|
|||||
|
2024
Q2 | $53.4K | Sell |
|
|||||
|
2024
Q1 | $436K | Sell |
|
|||||
|
2023
Q4 | $8.04M | Buy |
|
|||||
|
2023
Q3 | $332K | Sell |
|
|||||
|
2023
Q2 | $347K | Sell |
|
|||||
|
2023
Q1 | $360K | Buy |
|
|||||
|
2022
Q4 | $109K | Sell |
|
|||||
|
2022
Q3 | $706K | Sell |
|
|||||
|
2022
Q2 | $3.08M | Buy |
|
|||||
|
2022
Q1 | $369K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $125K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $426K | Sell |
|
|||||
|
2020
Q4 | $6.7M | Buy |
|
|||||
|
2020
Q3 | $428K | Sell |
|
|||||
|
2020
Q2 | $1.31M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $53K | Sell |
|
|||||
|
2019
Q2 | $1.12M | Sell |
|
|||||
|
2019
Q1 | $1.53M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $498K | Sell |
|
|||||
|
2018
Q2 | $521K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $4.93M | Sell |
|
|||||
|
2015
Q3 | $4.84M | Buy |
|
|||||
|
2015
Q2 | $1.48M | Buy |
|
|||||
|
2015
Q1 | $857K | Sell |
|
|||||
|
2014
Q4 | $1.1M | Sell |
|
|||||
|
2014
Q3 | $3.52M | Buy |
|
|||||
|
2014
Q2 | $1.14M | Sell |
|
|||||
|
2014
Q1 | $4.77M | Buy |
|
|||||
|
2013
Q4 | $506K | Buy |
|